All companies › GRCE

GRCE · Grace Therapeutics, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys9
Open-market sells0
Total purchased$201,593
Unique insiders buying1
Avg price paid$2.06
Research cases0
Last filing2026-10-12

Average price paid is weighted by shares, so a large purchase counts for more than a small one. It is what insiders reported paying, not a target or a fair value.

Insider flow: Buying only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-21 — Opaleye Management Inc. · bought 9,771 @ $2.10 2026-09-23 — Opaleye Management Inc. · bought 5,318 @ $2.10 2026-09-29 — Opaleye Management Inc. · bought 7,849 @ $2.09 2026-10-01 — Opaleye Management Inc. · bought 38,796 @ $2.04 2026-10-02 — Opaleye Management Inc. · bought 20,000 @ $2.07 2026-10-05 — Opaleye Management Inc. · bought 1,694 @ $2.06 2026-10-08 — Opaleye Management Inc. · bought 2,077 @ $2.02 2026-10-09 — Opaleye Management Inc. · bought 5,340 @ $2.04 2026-10-12 — Opaleye Management Inc. · bought 7,215 @ $2.02
2026-09-212026-10-12

Insider cost basis

Share-weighted average price across 9 reported purchases, with the full range of prices paid. Purchases only — averaging a sale into an "insider cost" would describe a price nobody paid.

$2.02 $2.10
$2.06 weighted average insider purchase price

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Opaleye Management Inc. 10% owner
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $GRCE is the reading of them — and for this company, that is what the list below says it is, no more.

  • Insider cost basisShare-weighted average price paid across the 9 reported purchases, with the full range, against the current price.
  • Insider participationWho bought, how often, and how the buying is distributed across the people filing — one person repeating is not several agreeing.
  • Transaction timelineThe [{'transaction_date': '2026-10-12', 'insider_name': 'Opaleye Management Inc.', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 7215.0, 'price': 2.02, 'value': 14574.3, 'is_buy': True}, {'transaction_date': '2026-10-09', 'insider_name': 'Opaleye Management Inc.', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 5340.0, 'price': 2.0446, 'value': 10918.16, 'is_buy': True}, {'transaction_date': '2026-10-08', 'insider_name': 'Opaleye Management Inc.', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 2077.0, 'price': 2.0175, 'value': 4190.35, 'is_buy': True}, {'transaction_date': '2026-10-05', 'insider_name': 'Opaleye Management Inc.', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 1694.0, 'price': 2.06, 'value': 3489.64, 'is_buy': True}, {'transaction_date': '2026-10-02', 'insider_name': 'Opaleye Management Inc.', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 20000.0, 'price': 2.0684, 'value': 41368.0, 'is_buy': True}, {'transaction_date': '2026-10-01', 'insider_name': 'Opaleye Management Inc.', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 38796.0, 'price': 2.0353, 'value': 78961.5, 'is_buy': True}, {'transaction_date': '2026-09-29', 'insider_name': 'Opaleye Management Inc.', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 7849.0, 'price': 2.09, 'value': 16404.41, 'is_buy': True}, {'transaction_date': '2026-09-23', 'insider_name': 'Opaleye Management Inc.', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 5318.0, 'price': 2.1, 'value': 11167.8, 'is_buy': True}, {'transaction_date': '2026-09-21', 'insider_name': 'Opaleye Management Inc.', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 9771.0, 'price': 2.1, 'value': 20519.1, 'is_buy': True}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for GRCE today: no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.